Next‐Generation Vaccines for Co‐Circulating PEDV and TGEV: Integrating Nucleic Acid Platforms, Mucosal Delivery, and AI–Driven Antigen Design
Transboundary and Emerging Diseases · 2025-01 · 2025 (1)
DOI: 10.1155/tbed/2014296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 04.12.2025. Verfasst von Xiaojun Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Jilin Agricultural University, Changchun, 130118, Jilin, China, jlau.edu.cn. Hauptthemen laut MEDLINE: Viral Vaccines, Transmissible gastroenteritis virus, Porcine epidemic diarrhea virus, Gastroenteritis, Transmissible, of Swine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Health Commission of Hunan Province.
Abstract (Originalsprache)
Porcine epidemic diarrhea virus (PEDV) and transmissible gastroenteritis virus (TGEV) are causative agents of acute enteric diseases in pigs and have a high contagion potential. These coronaviruses (CoVs) impose substantial economic losses on global pork production, particularly affecting lactating piglets where coinfections occur. Although traditional vaccines offer partial protection, their efficacy is increasingly challenged by the continuous emergence of mutated strains of PEDV and TGEV. This underscores the demand for novel vaccines with improved protective efficacy and cost‐effectiveness. Emerging vaccine technologies, such as nucleic acid vaccines, genetically engineered subunit vaccines, and live vector vaccines, have received widespread attention because of their advantages in terms of safety, stability, targeted delivery, economy, and ease of use. This review summarizes recent advances in PEDV and TGEV vaccine development, highlighting both their potential and limitations. More importantly, we prospect novel techniques that may supplement the status gaps and lead to breakthroughs in blocking the transmission of these CoVs. Notable research priorities encompass mucosal immunity mechanisms, vertical transmission prevention strategies, and computational immunogen design leveraging artificial intelligence (AI). Overall, a deeper understanding of the pathogens coupled with technological advances is expected to accelerate the control of and effective response to pathogenic CoVs, thereby safeguarding the stability of animal husbandry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Jilin Agricultural University, Changchun, 130118, Jilin, China, jlau.edu.cn.
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun, 13000…
- Key Laboratory of Special Animal Epidemic Disease, Ministry of Agriculture, Jilin Provincial International Cooperation Key Laboratory for Science and Technology Innovation of Special Animal and Plants, Institute of Spec…
- Center for Infectious Medicine and Vaccine Research, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China, cpu.edu.cn.
- Innovation Center for Nucleic Acid Medicine, Institute for Innovative Drug Development and Life Sciences, Wuxi, 214000, China.
ORCID-Profile: Xiaojun Hu, Guixue Hu, Feihu Yan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Health Commission of Hunan Province
Zitieren
APA
Hu, X., Wang, Z., Wang, S., Sun, H., Feng, N., Li, E., Xia, X., Hu, G., Yan, F., & Li, B. (2025). Next‐Generation Vaccines for Co‐Circulating PEDV and TGEV: Integrating Nucleic Acid Platforms, Mucosal Delivery, and AI–Driven Antigen Design. Transboundary and Emerging Diseases, 2025(1). https://doi.org/10.1155/tbed/2014296
Vancouver
Hu X, Wang Z, Wang S, Sun H, Feng N, Li E, et al. Next‐Generation Vaccines for Co‐Circulating PEDV and TGEV: Integrating Nucleic Acid Platforms, Mucosal Delivery, and AI–Driven Antigen Design. Transboundary and Emerging Diseases. 2025;2025(1). doi:10.1155/tbed/2014296
BibTeX
@article{Hu2025,
author = {Hu, Xiaojun and Wang, Zhenshan and Wang, Shen and Sun, Hongyu and Feng, Na and Li, Entao and Xia, Xianzhu and Hu, Guixue and Yan, Feihu and Li, Bin},
title = {Next‐Generation Vaccines for Co‐Circulating PEDV and TGEV: Integrating Nucleic Acid Platforms, Mucosal Delivery, and AI–Driven Antigen Design},
journal = {Transboundary and Emerging Diseases},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/tbed/2014296}
}
EUVIMED